Industrials · Aerospace & Defense · Synthos Deep Dive · 2026-07-03
| Verdict | Hold — systematic Synthos tier |
| Price (2026-07-02) | $302.07 · market cap ~$56.3B |
| Synthos scores (0–10) | Downside Risk 5 · Growth Quality 6 · Exponential Potential 3 |
| Synthos fair value (base case) | ~$290 → −4% · full range $210 (bear) – $345 (bull) |
| Street consensus | $347 (high $364 / low $323; 24 Buy · 6 Hold · 2 Sell) — context, not our anchor |
| Valuation | 33× trailing EPS · 28× FY26E · 26× FY27E · 22× FY28E · 17× FY30E · EV/S 3.0× · EV/EBITDA 17.4× |
| Exponential Potential | 3/10 · Low — ~16% forward EPS CAGR is margin-driven; revenue only grows ~6–8%/yr and the TAM is government-budget-bound |
| Technicals | Downtrend — $302, −20% off 52-wk high, below 50/200-DMA, RSI 43, +19.8% 12-mo (SPY +20.6%) |
| Conviction | Low — zero expert voices in the Synthos KB; this is a numbers-and-quant call |
| Position sizing | Satellite/defensive, ~1–3% if entered — a steady holder, not a high-conviction core |
| Next catalyst | 2026-07-23 Q2'26 earnings (Street EPS $2.79, rev ~$5.79B) |
| Single biggest risk | US defense-budget dependence + 2.8× net-debt/EBITDA if a program or CR (continuing resolution) stalls revenue |
One-line thesis. L3Harris is a well-run, mid-cap prime defense contractor riding a genuine demand tailwind (record $40.7B backlog, 1.4× book-to-bill, management raising FY26 EPS guidance) — but at 28× forward earnings, single-digit revenue growth, 2.8× leverage and mediocre returns on capital, the price already reflects the good news, so we rate it Watch rather than Buy.
L3Harris builds the electronics, radios, sensors, satellites and missile parts that the US military and its allies buy — night-vision goggles, secure battlefield radios, spy-plane systems, missile propulsion. It's the sixth-largest US defense contractor, formed when Harris and L3 merged in 2019.
The business is healthy: it has a record pile of signed-but-not-yet-delivered orders ($40.7 billion), and for every dollar of work it delivered last quarter it booked $1.40 of new orders — that's growth in the pipeline. Management just raised its profit forecast for the year. But the stock isn't cheap: you're paying about 28 years of forecast profit for it, and the company carries a fair amount of debt.
Our verdict is Watch — a solid company, but at today's price the easy money looks made. We'd want a lower price or a clearer growth acceleration before calling it a Buy.
Here's what the three scores mean in everyday terms:
The one big worry: almost all of L3Harris's money comes from the US government and allied defense budgets. If Washington passes a stop-gap budget ("continuing resolution") or cuts spending, revenue stalls — and with the debt this company carries, that would sting more than for a cash-rich peer.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Above 70 (red band) = overbought, below 30 (green band) = oversold. Currently 51.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Solid = LHX · dashed = S&P 500 · dotted = XLI (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
L3Harris Technologies (NYSE: LHX) is a Melbourne, Florida–based prime defense contractor, the product of the 2019 merger of Harris Corporation (founded 1895) and L3 Technologies. It sells mission systems, tactical communications, electronic warfare, ISR (intelligence/surveillance/reconnaissance), space payloads, night vision, and — since the 2023 Aerojet Rocketdyne acquisition — missile and space propulsion. It employs ~47,000 people. Fiscal year ends the Friday nearest December 31.
Revenue mix. Note a wrinkle: the FMP product segmentation still reports the legacy four-segment structure (Integrated Mission Systems, Space & Airborne Systems, Communication Systems, Aerojet Rocketdyne), while as of 2026 management has re-organized into three reportable segments — Space & Mission Systems, Communication & Spectrum Dominance, and Missile Solutions (per the Q1'26 earnings release). We show both so the numbers reconcile:
The strategic frame management uses is the "Trusted Disruptor" strategy and a "2028 Financial Framework" — margin expansion, cost-out ("LHX NeXt"), and monetizing legacy assets. There is also a planned public offering / partial spin of Missile Solutions flagged in the filing.
There is zero expert coverage of LHX in the Synthos knowledge base. total_claims is 0; there are no net-bullish or cautionary voices, and no claim_id values exist to cite. Per Synthos house standard, we do not fabricate conviction: this verdict is entirely fundamentals- and quant-driven, built from FMP financials, analyst estimates, management's own SEC-filed guidance (half-weighted, §9), and the technical block.
What that means for the reader: treat the conviction rating as Low by construction. The bull/base/bear scenarios in §3 are our own scenario model, not an aggregation of outside experts. Where the Street disagrees with us (it is more bullish), we show that as context in §6 — but we anchor to our own base case, not to the consensus target.
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
| Score | 0–10 | The read |
|---|---|---|
| Downside Risk (lower = safer) | 5 · Moderate | Beta 0.75 and a record $40.7B backlog (1.4× book-to-bill) cushion the downside, but net-debt/EBITDA 2.8× and a full 28× forward multiple offset that — and the whole revenue base is US-budget-dependent. |
| Growth Quality | 6 · Decent | ~16% forward EPS CAGR (FY25→FY30E) and expanding margins (segment op-margin 15.7%, up), but revenue only compounds ~6–8%/yr and ROIC is a mediocre ~5% against a goodwill-heavy balance sheet (goodwill+intangibles are 64% of assets). |
| Exponential Potential | 3 · Low | Single-digit revenue growth, a $56B cap, and a TAM bounded by government defense budgets. A fine compounder; not a multibagger. |
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.
| Case | Key assumptions | Fair value |
|---|---|---|
| Bull | Defense-spending upcycle sustains; backlog converts fast; margin framework delivers; Missile Solutions spin unlocks value. FY27E EPS beats to ~$12.3 (vs $11.62 cons); the market pays a premium ~28× for a de-risked defense compounder. | ~$345 (+14%) |
| Base (our anchor) | Estimates roughly hit — FY27E EPS $11.62; a mid-single-digit-revenue, margin-expanding defense prime earns a ~25× multiple. | ~$290 (−4%) |
| Bear | A continuing resolution / budget cut stalls revenue; margin framework slips; leverage (2.8×) amplifies an earnings miss. FY27E EPS misses to ~$10.5; multiple de-rates to ~20×. | ~$210 (−30%) |
Synthos fair value = the base case, ~$290 (−4%), with the full $210–$345 span as the honest range. Our base sits below the Street's $347 consensus — we give less benefit of the doubt to the forward multiple and take the leverage/budget risk more seriously. This is a tracked call — the Forecaster Scorecard grades it once it matures.
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). LHX is a steady defense compounder — decidedly not an exponential:
Exponential Potential: Low (3/10). Own LHX (if at all) for steady low-teens total return via EPS growth + capital return, not for a fast multibagger. A small, accelerating name would score far higher on this axis; LHX honestly does not.
LHX is not cheap, not egregious. Trailing 33× EPS, EV/EBITDA 17.4×, EV/S 3.0×, P/FCF ~22×. The forward multiple compresses as margins expand: 28× FY26E → 26× FY27E → 22× FY28E → 17× FY30E on consensus EPS. The PEG-style read: ~28× forward against ~16% forward EPS growth is roughly a 1.8× forward PEG — full, but not absurd for a low-beta defense compounder with a record backlog.
The bull's case is that (a) the backlog (1.4× book-to-bill) de-risks the revenue, (b) the margin framework and LHX NeXt cost-out keep EPS compounding faster than revenue, and (c) a Missile Solutions spin surfaces value. The bear's case is that (a) 2.8× leverage magnifies any budget-driven revenue miss, (b) ROIC is only ~5% (below cost of capital on a goodwill-heavy base), and (c) at 28× forward there's simply little margin of safety.
Street targets (context): consensus $347 (high $364, low $323; 24 Buy / 6 Hold / 2 Sell). Our base-case FV of ~$290 is below the Street — we discount the forward multiple and weight the leverage/budget risk more heavily. When our number is below consensus, we say so: this is why the verdict is Watch, not Buy.
L3Harris's moat is the standard prime-contractor moat: (1) entrenched, long-cycle program positions with the US DoD and allies (switching costs are enormous mid-program); (2) classified/cleared capabilities and facilities that create high barriers to entry (ISR, EW, secure comms, space payloads); (3) scale and vertical integration — the Aerojet Rocketdyne acquisition brought captive missile/space propulsion. The record $40.7B backlog is the tangible expression of that moat — multi-year revenue visibility.
The limits: it is the #6 US prime (behind LMT, RTX, GD, NOC, BA), a price-taker on most cost-plus and fixed-price government contracts, subject to budget cycles and unilateral government contract action, with only ~5% ROIC on a goodwill-heavy base.
Peer set (from FMP, market cap): Northrop Grumman $78B (the closest pure-play defense comp), United Rentals $69B, PACCAR $63B, Carrier $58B, AMETEK $54B, HEICO $50B, Axon $48B, Ferguson $45B, Roper $37B. Note the FMP peer list is a mixed industrials bag; the truest defense comps for LHX are NOC, plus (not listed) LMT, RTX, GD. Among these, LHX trades at a mid-range multiple with lower ROIC than the higher-quality industrials (HEICO, Roper, AMETEK) but a genuine defense tailwind those lack.
- FY2026 revenue $23.0–23.5B and GAAP diluted EPS $11.40–11.60 (raised from a prior $11.30–11.50).
- Segment operating margin "low 16%" for the year; operating cash flow ~$3.6B, capex ~$600M (implying ~$3.0B FCF).
- Record backlog $40.7B, book-to-bill 1.4×, orders $7.8B in the quarter.
- Reaffirmed the 2028 Financial Framework and flagged a planned public offering of the Missile Solutions business.
- CEO Chris Kubasik framed it around the "Trusted Disruptor" strategy and "demand accelerating." Half-weight this — it's management's own book — but the guidance raise and the backlog are corroborated by the reported Q1 numbers.
Thesis tripwires (what would change the call): a book-to-bill falling below 1.0× for two quarters; a budget-driven revenue guide-down; leverage rising back toward 3.5×+; or the margin framework visibly slipping. A pullback into the low-$250s with backlog intact would flip this toward Buy — Tactical.
Watch. L3Harris is a genuinely well-run mid-cap defense prime in a real demand upcycle — record $40.7B backlog, 1.4× book-to-bill, +33% Q1'26 EPS, expanding margins, and a management team that just raised full-year guidance. Those are all Buy-shaped facts. But the stock is priced for them: 28× forward, ~6% revenue growth, 2.8× leverage, ~5% ROIC, and a technical downtrend (below both moving averages, −20% off its high). Our base-case fair value (~$290) sits below both the current price and the Street's $347 — so the honest verdict is Watch, not Buy. We'd want a lower entry (low-$250s) or a clearer growth/deleveraging inflection to upgrade.
claim_id values are cited because none exist. Fabricated conviction is structurally impossible (claim-ID reconciliation), and we state the absence of coverage plainly rather than manufacturing a thesis.